The treatment of human African trypanosomiasis

Adv Parasitol. 1994;33:1-47. doi: 10.1016/s0065-308x(08)60410-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Diminazene / adverse effects
  • Diminazene / pharmacokinetics
  • Diminazene / therapeutic use
  • Eflornithine / adverse effects
  • Eflornithine / pharmacokinetics
  • Eflornithine / therapeutic use
  • Humans
  • Melarsoprol / adverse effects
  • Melarsoprol / pharmacokinetics
  • Melarsoprol / therapeutic use
  • Nifurtimox / adverse effects
  • Nifurtimox / pharmacokinetics
  • Nifurtimox / therapeutic use
  • Pentamidine / adverse effects
  • Pentamidine / pharmacokinetics
  • Pentamidine / therapeutic use
  • Suramin / adverse effects
  • Suramin / pharmacokinetics
  • Suramin / therapeutic use
  • Trypanocidal Agents / adverse effects
  • Trypanocidal Agents / pharmacokinetics
  • Trypanocidal Agents / therapeutic use*
  • Trypanosoma brucei gambiense*
  • Trypanosoma brucei rhodesiense*
  • Trypanosomiasis, African / drug therapy*

Substances

  • Trypanocidal Agents
  • Suramin
  • Pentamidine
  • Nifurtimox
  • Diminazene
  • Melarsoprol
  • Eflornithine